NASDAQ: NEPH
Nephros, Inc.
Healthcare · Medical - Instruments & Supplies
After hours: $4.27(0%) · as of 7:34 PM ET
Market Cap
$46.36M
52w High
$6.42
52w Low
$2.66
P/E
27.33
Volume
20.11K
Outstanding Shares
10.86M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 4.9% over the last year. Revenue grew 24.2% over the trailing twelve months. Operating margin moved from 8.01% to 7.92%. Free cash flow declined 133.1% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower with no clear directional signal from operating metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 7.92%. A decisive move in revenue — currently up 24.2% — would be the clearest signal to resolve the ambiguity.
Company profile
Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors.
Valuation
Stock splits
Every 9 shares became 1
Every 20 shares became 1
Profitability & growth
Analyst consensus
4
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 5, 2026
Q4 FY26 · EPS est $0.01 · Revenue est $5.42M
View